CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This study will assess the efficacy and safety of dexpramipexole as an adjunctive oral therapy in participants with inadequately controlled asthma...
Phase 3
Piaseczno, Poland and 125 other locations
The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...
Phase 3
Piaseczno, Poland and 117 other locations
The study is being conducted to evaluate the effect of 3 dosing regimens of povorcitinib on pulmonary function
Phase 2
Warszawa, Poland and 96 other locations
and safety of Atuliflapon administered once daily over a 12-week treatment period to adult participants with moderate to severe uncontrolled asthma...
Phase 2
Warszawa, Poland and 369 other locations
variable length study to evaluate the efficacy and safety of budesonide/glycopyrronium/formoterol inhaler in adults and adolescents with severe asthma...
Phase 3
Piaseczno, Poland and 478 other locations
compared to omalizumab* To evaluate the effect of dupilumab on asthma control at Week 24 compared to omalizumab* To evaluate the safety of ...
Phase 4
Warszawa, Mazowieckie, Poland and 94 other locations
birch pollen-induced allergic rhinoconjunctivitis, with or without asthma, when treated before and during the pollen season.Approximately 69...
Phase 3
Warsaw, Poland and 61 other locations
This study will evaluate the efficacy and safety of depemokimab (GSK3511294) in participants with CRSwNP.
Phase 3
Nadarzyn, Poland and 84 other locations
This is a randomized, double-blind, placebo-controlled, parallel-group, international, multicenter, Phase 3 study to evaluate the efficacy and safety...
Phase 3
Nadarzyn, Poland and 115 other locations
Clinical trials
Research sites
Resources
Legal